
News – Page 2
-
Several drug and device litigations ballooned in 2020. Some, including Zantac lawsuits, were affected by the year’s major recalls. Others, such…
-
JET 7 Xtra Flex Catheters Recalled After Injuries and Deaths
Penumbra issued an urgent voluntary recall of all JET 7 Catheters with Xtra Flex Technology after reports of death and injuries, according to…Michelle Llamas December 21, 2020 -
Status of Bard, Ethicon and Atrium Hernia Mesh Lawsuits
Three medical device companies face 14,900 hernia lawsuits pending in three federal multidistrict litigations across the country. The COVID-19…Michelle Llamas October 26, 2020 -
Johnson & Johnson Settles 1,000 Talc Lawsuits for $100M
After a seven-month lull due to COVID-19, talcum powder litigation is back in the news and in a big way.Michelle Llamas October 13, 2020 -
FDA Approves First New Mesothelioma Treatment in 16 Years
On Oct. 2, 2020, the Food and Drug Administration announced it had approved Bristol-Myers Squibb’s Opdivo (nivolumab) in combination with Yervoy (ipilimumab)…Michelle Llamas October 6, 2020 -
FDA Issues Guidance to Control NDMA in Zantac, Other Drugs
The Food and Drug Administration has issued guidance for drugmakers on how to detect and prevent potential cancer-causing nitrosamine contamination in drugs. …Michelle Llamas October 6, 2020 -
NIH Study Gathers Data on COVID-19 Immunity, Prevalence
A nationwide National Institutes of Health (NIH) study hopes to gather data on COVID-19 antibodies to shed light on how many…Michelle Llamas October 6, 2020 -
Association of Marketing and Communication Professionals Recognizes Drugwatch in Awards Spotlight
The Association of Marketing and Communication Professionals has honored Drugwatch for its consequential reporting on the vaping industry’s marketing practices.Emily Miller October 5, 2020 -
FDA Issues Warning on ‘Benadryl Challenge’
The U.S. Food and Drug Administration issued a warning against taking too much of the allergy medicine Benadryl (diphenhydramine) after teens began ingesting high…Michelle Llamas September 29, 2020
Who Am I Calling?
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617